Vertical fascial traction outperformed standard mesh-based closure in open abdomen therapy
Open abdomen treatment leaves the fascia intentionally unclosed after laparotomy, a move reserved for patients with severe intra-abdominal sepsis, trauma, or abdominal compartment syndrome when immediate closure would be dangerous. The central goal is not to keep the abdomen open; it is to reach early definitive fascial closure before edema, inflammation, and tissue retraction make that impossible. Once the fascial edges drift apart, the biology of closure turns against the surgeon: swelling worsens approximation, the abdominal wall stiffens, and the price of delay becomes a planned ventral hernia or more complex reconstruction later on.
In that setting, traction matters. The newer vertical mesh-mediated fascial traction approach, using Fasciotens® Abdomen, is designed to pull the fascial edges upward rather than laterally, countering retraction in a way that may better preserve midline apposition. In this registry-based cohort, that strategy was associated with higher closure rates than conventional vacuum-assisted wound closure with mesh-mediated fascial traction, the method widely treated as standard care in many centers.
Registry data showed a closure advantage for the vertical approach
The analysis drew on the European Hernia Society Open Abdomen Registry between 2015 and 2024. Among 1119 open abdomen cases, 39 patients received vertical mesh-mediated fascial traction and 675 received vacuum-assisted wound closure with mesh-mediated traction. Because treatment assignment was not randomized, investigators used propensity score matching based on sepsis at open abdomen initiation and initial fascial defect width. After matching, each group included 28 patients.
Even in that constrained sample, the difference in closure rates was difficult to ignore. In the matched cohorts, definitive fascial closure was achieved in 89.3% of patients treated with vertical traction versus 60.7% with the horizontal mesh-based technique in the ITT-like analysis. In the PP-like analysis, closure reached 100.0% versus 69.6%, respectively. Both comparisons were statistically significant with p = .01. Logistic regression in the matched cohort also linked vertical traction to higher odds of closure, with an odds ratio of 5.39 and a 95% confidence interval from 1.31 to 22.25.
The signal is encouraging, but the interval is wide enough to remind clinicians how little data sit beneath the estimate.
Why the mechanism makes clinical sense
The open abdomen behaves like a dynamic wound under constant mechanical stress. As bowel edema settles and negative pressure evacuates fluid, traction systems attempt to restore the fascia to the midline before collagen remodeling fixes the wound in a widened position. Horizontal mesh traction distributes force across the fascial plane, while a vertical vector may better oppose the natural lateral drift of the abdominal wall and reduce the tendency toward retraction. In practical terms, the vertical system may preserve the geometry needed for closure while the patient is still recovering from shock, contamination, or visceral swelling.
That biological logic does not prove superiority, but it helps explain why a mechanical change in force direction could matter in a disease process governed by edema, tissue tension, and progressive loss of abdominal domain. In open abdomen care, the difference between closure and hernia is often measured in days, not months.
Safety signals were mixed and need cautious reading
The cohort also offered a few safety and resource-use signals. ICU stay and ventilation duration were longer in the vertical traction group. The study does not establish whether that reflects the device, the underlying illness burden, or residual confounding left behind after matching. In a retrospective surgical registry, longer critical care support can easily track with case severity rather than with the closure technique itself.
Enteroatmospheric fistula occurred in 0% of the vertical group and 10.7% of the horizontal group, with p = .08. The comparison did not reach conventional statistical significance, but the direction of effect deserves attention because fistula formation is one of the most feared complications in open abdomen management. Even a small numerical difference can carry major bedside consequences when the event itself can reshape the entire reconstructive plan.
What the registry can and cannot tell surgeons
This is not a randomized trial, and the design does not support a declaration that vertical traction is definitively better. Only 39 patients in the entire registry received the vertical method, and just 28 were included after matching. Residual imbalance remained possible despite propensity scoring, and the report itself emphasizes the observational, exploratory nature of the findings. The confidence interval around the odds ratio was broad, which limits precision and should temper enthusiasm.
Still, the study does something clinically useful: it tests whether a newer vector of fascial traction can improve the outcome that matters most in open abdomen therapy. Definitive fascial closure is the endpoint surgeons care about because it determines whether the patient exits the hospital with an intact abdominal wall or a future reconstruction problem. By that measure, the vertical approach deserves prospective testing under standardized protocols rather than casual adoption on the basis of early promise alone.
Open abdomen surgery still revolves around timing, tension, and tissue biology
The broader lesson from this registry is familiar to anyone managing severe abdominal catastrophe. Open abdomen care succeeds when the team limits edema, prevents fascial drift, and closes early enough to avoid the spiral toward chronic abdominal wall failure. Negative pressure therapy helps control the wound environment, but traction supplies the mechanical force needed to bring tissue home. Direction of that force may not be a minor technical detail; it may be one of the variables that decides whether closure remains feasible at all.
The study was registered in the German Clinical Trials Register as DRKS00037753 on 2 June 2026. Larger prospective studies are still needed to determine whether the apparent closure advantage of vertical mesh-mediated fascial traction holds across broader populations, different degrees of sepsis, and more standardized treatment pathways. Until then, the most responsible reading is restrained: the new technique looks promising, but the current evidence remains exploratory rather than confirmatory.